Loading company…
Neuromedical develops therapies for cognitive impairments associated with Alzheimer's disease.
Founded in 2016 and based in Lodz, Poland, Neuromedical develops therapies for Alzheimer's disease, with a focus on cognitive impairments. In May 2025, it raised PLN 3 million in seed funding from Hard2beat. The funding will support clinical trials, EU certification validation, an FDA submission, a pilot assembly line, and digital tools for remote therapy monitoring and patient adherence.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in